DLRC achieves King’s Award for Enterprise in International Trade

DLRC Ltd., established in 2005, is headquartered in Letchworth Garden City, Herts, and is a subsidiary of DLRC Holdings Ltd. Their notable growth has secured them the International Trade Award in 2017 and 2021. A testament to their unwavering dedication to excellence and innovation on the global stage.

Specialising in pharmaceutical, biotechnology and MedTech sectors, including advanced therapies and AI innovations, DLRC offers unparalleled regulatory affairs services to the life sciences sector. DLRC works with a range of clients, from top 5 pharma companies to SMEs and start-ups, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.

DLRC has achieved this milestone through global growth initiatives, including expanding its UK operations, acquiring Orphix Consulting based in Munich in 2020, and incorporating DLRC Inc. in Boston last year. These strategic manoeuvres and the team’s unwavering dedication to excellence have resulted in an impressive 88.56% increase in total overseas earnings over the past three years. Additionally, the percentage of sales exported has risen from 47% to 57% during the same period. Beyond numbers, the award reflects DLRC’s mission to provide innovative regulatory affairs solutions that propel clients forward and significantly contribute to advancing global healthcare.

About King’s Award for Enterprise

Formerly known as The Queen’s Awards for Enterprise, the King’s Awards for Enterprise was renamed last year to honour His Majesty The King’s commitment to recognising outstanding UK businesses. Now in its 58th year, the Award program is acclaimed and recognised in the UK enterprise. These awards celebrate the success of visionary companies, pioneers in innovative products, champions of social mobility, and advocates for sustainable development.

For more information about DLRC and their award-winning regulatory affairs support, contact their team at [email protected]

For media enquires please contact [email protected].

More within